1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase 2 Open-label Study to Evaluate the Safety of Laruparetigene Zovaparvovec Administered Bilaterally in Male Participants With X-Linked Retinitis PigmentosaEye Diseases, Hereditary, eye disorder, retinal degeneration, retinal disorderActive, not recruitingPhase 22026-06-25NCT07174726